日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group

一线贝伐珠单抗联合化疗（伴或不伴维持治疗）治疗转移性乳腺癌：希腊肿瘤研究组的一项观察性研究

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol29020105
Kokkali, Stefania; Saloustros, Emmanouil; Stefanou, Dimitra; Makrantonakis, Paris; Kentepozidis, Nikolaos; Boukovinas, Ioannis; Xenidis, Nikolaos; Katsaounis, Panagiotis; Ardavanis, Alexandros; Ziras, Nikolaos; Christopoulou, Athina; Rigas, George; Kalbakis, Kostas; Vardakis, Nikolaos; Emmanouilides, Christos; Athanasiadis, Ilias; Anagnostopoulos, Athanassios; Hatzidaki, Dora; Prinarakis, Efthimios; Simopoulou, Foteini; Kotsakis, Athanasios; Georgoulias, Vassilis
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Nab-paclitaxel as second-line treatment in advanced gastric cancer: a multicenter phase II study of the Hellenic Oncology Research Group

纳米白蛋白紫杉醇作为晚期胃癌二线治疗：希腊肿瘤研究组的一项多中心II期研究

期刊:Annals of Gastroenterology
影响因子:2.2
doi:10.20524/aog.2017.0215
Katsaounis, Panagiotis; Kotsakis, Athanasios; Kentepozidis, Nikolaos; Polyzos, Aris; Bakogeorgos, Marios; Koinis, Filippos; Vamvakas, Lambros; Vardakis, Nikolaos; Kalbakis, Kostas; Boukovinas, Ioannis; Varthalitis, Ioannis I; Prinarakis, Efthimios; Georgoulias, Vassilis; Souglakos, John
胃癌
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

Panitumumab in combination with modified docetaxel/cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group

帕尼单抗联合改良的多西他赛/顺铂/5-氟尿嘧啶方案作为胃癌和胃食管交界处腺癌一线治疗：希腊肿瘤研究组开展的一项多中心II期研究

期刊:Annals of Gastroenterology
影响因子:2.2
doi:10.20524/aog.2018.0311
Kentepozidis, Nikolaos; Economopoulou, Panagiota; Liontos, Michael; Kotsakis, Athanasios; Boukovinas, Ioannis; Vardakis, Nikolaos; Kontopodis, Emmanouil; Prinarakis, Efthimios; Skaltsi, Teressa; Souglakos, John; Georgoulias, Vassilis
胃癌
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

S-glutathionylation of IRF3 regulates IRF3-CBP interaction and activation of the IFN beta pathway

IRF3 的 S-谷胱甘肽化调节 IRF3-CBP 相互作用和 IFNβ 通路的激活

期刊:EMBO Journal
影响因子:9.4
doi:10.1038/emboj.2008.28
Efthimios Prinarakis, Eleni Chantzoura, Dimitris Thanos, Giannis Spyrou
信号转导
发表日期：2008
文献求助 收藏

Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant

出现了一种源自 SHV-5 变体的耐抑制剂 β-内酰胺酶 (SHV-10)

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.41.4.838
Prinarakis, E E; Miriagou, V; Tzelepi, E; Gazouli, M; Tzouvelekis, L S
发表日期：1997
文献求助 收藏